["{\n\"step_by_step_thinking\": \"There is a study on HER-2/neu proto-oncogene expression in serous ovarian neoplasms which shows that expression of the gene may be associated with high stage in serous ovarian neoplasms. However, there is no mention of urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy. Therefore, we cannot draw a conclusion about HER2 immunoreactivity providing prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy based on the provided documents.\",\n\"answer_choice\": B"]